News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Daily News Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions L.A. McKeown March 02, 2017
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017
News Daily News DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed Michael O'Riordan February 16, 2017
News Daily News Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds? Michael O'Riordan February 02, 2017
News Daily News TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years Michael O'Riordan January 20, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner Las Noticias y Blogs Más Populares de TCTMD en 2016 Shelley Wood December 29, 2016
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Daily News After EXCEL and NOBLE, New Meta-analysis Revisits PCI vs Surgery for Unprotected Left Main CAD Michael O'Riordan December 14, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Industry News Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan November 29, 2016